131941-27-0Relevant academic research and scientific papers
NAPHTHALENE DERIVATIVE
-
Paragraph 0330, (2013/06/27)
The present invention provides compounds which can regulate VCP activity. The present invention provides the compound of formula (I) (R is as defined in the description) or oxides, esters, prodrugs, pharmaceutically acceptable salts or solvates thereof. The compounds can regulate VCP activity, and thus are useful for treating VCP-mediated diseases such as neurodegenerative diseases.
AGENT FOR TREATMENT OF EYE DISEASES
-
Paragraph 0083-0084; 0189-0190, (2013/08/15)
The present invention provides agents effective to treat eye diseases, pharmaceutical compositions comprising them, methods for preparing pharmaceuticals for treatment of eye diseases comprising using the agents, use of the agents in manufacture of pharma
